Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival.
about
Molecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast CarcinogenesisPotential use of COX-2-aromatase inhibitor combinations in breast cancerInflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancerFunctional promoter -765 G > C variant in COX-2 gene is associated with the susceptibility of breast cancer in Chinese Han women.Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control studyCOX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatmentCyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patientsAssociation of the three common SNPs of cyclooxygenase-2 gene (rs20417, rs689466, and rs5275) with the susceptibility of breast cancer: an updated meta-analysis involving 34,590 subjects.Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients.Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancerRole of traditional and new biomarkers in breast carcinogenesis.COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirinProtein kinase C alpha expression in breast and ovarian cancer.Confocal laser endomicroscopy in head and neck malignancies using FITC-labelled EpCAM- and EGF-R-antibodies in cell lines and tumor biopsies.COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoidImpact of cyclooxygenase-2 over-expression on the prognosis of breast cancer patients.Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.COX2 overexpression is a prognostic marker for Stage III breast cancer.Role of Aspirin in Breast Cancer Survival.A high-performance microsystem for isolating circulating tumor cells.Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome.Evaluation of tumor-specific promoter activities in melanoma.Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma.Engineered nanopore of Phi29 DNA-packaging motor for real-time detection of single colon cancer specific antibody in serum.Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue.Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer.Euterpe oleracea extract inhibits tumorigenesis effect of the chemical carcinogen DMBA in breast experimental cancer.High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes.Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density.Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy.
P2860
Q26744296-0F13F1CB-0730-4A17-AA7F-628D3021796BQ28187414-608B3BBC-E13A-4028-ADE0-CA8367337AC1Q28218639-DB7632EF-C1DC-4B7A-84CA-B78CA21E424CQ33600759-E6392851-2321-48E3-A2F3-D1451FF7EEE5Q33741123-05BF7DBC-A0B4-4E62-BB86-6BBEC5403378Q33877411-8DBAF369-8382-4AFD-904A-C3819352EA11Q33932996-AEC5428B-409C-444D-9C11-44A07B67B99AQ34119332-0FDCB4FD-B1CE-4636-9351-D2E20C4075E1Q34206453-E319B815-2312-4013-B2EB-F5EC8CCCACB1Q34316720-92E503FF-75B4-4540-8D4A-3B9CDB9D6D44Q34996098-7BBA693F-CC3A-43E2-996C-C417BF01C836Q35108403-A3E542B1-0699-4D42-8CFC-57E4DFE5593CQ35572905-D98FAA40-0C9B-4D5D-BE6A-FD5964F7C58FQ35797114-E3BE8519-002B-4016-A9E4-1B7BC7987F87Q35905995-E910638D-84EE-45BF-B12B-0CB1976E359EQ36255253-C0F659E2-A141-451C-87A5-6867BFAD0FC6Q36694470-B1FEC45C-24F9-4E5C-8DDA-F11E7218093AQ37033840-C8A77FFB-937C-4F0B-BEDF-8F0F505526DCQ37088155-042432B6-8C50-4464-9FD3-8C95A8A17F20Q37701526-1CC4CFCA-0AAA-4C02-AA34-5021E33E9FBBQ38474547-9C5E7432-E391-45D5-8CD8-D10E8491C6C6Q38735032-13BD6A9B-802B-4CA3-A764-4EE7544342F7Q39491322-B49D67CA-920C-42A8-BBA3-54891A934F1DQ40233359-E8F680D4-301E-43B4-AD99-5F50CE3752E2Q40461124-1D358736-D7A3-4D7F-BAED-BF904A713970Q41324942-22B32593-320E-4523-B82D-AC0FF5522C3AQ41920145-CBCCD14B-9BB3-41E5-A02A-4005144ECDBBQ46450697-8DFBBAE3-4A3B-402F-A9D4-384E9B178725Q46827099-914D5C24-1CCB-4417-9A9D-8B5853FCCED7Q47273449-98EC4F33-4493-44DD-A012-ABA67FB728C4Q51393573-A745A3CD-5D8E-46E2-B01B-767BE71519A8Q51730817-D30C03F6-E8CB-422B-AC91-69E1BC06C508Q53176736-2E8971B9-260E-49B9-AEF7-5058AC744E1FQ53389613-4DC14664-E07C-4DDB-9511-590E84EBB81EQ53400538-BC9F5D6F-E92A-4BED-ABF5-5D7D3397F0FFQ54609676-7012A493-D30E-4452-AAF6-57A6B70D2AA2
P2860
Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Correlation of COX-2 and Ep-CA ...... er and its impact on survival.
@ast
Correlation of COX-2 and Ep-CA ...... er and its impact on survival.
@en
type
label
Correlation of COX-2 and Ep-CA ...... er and its impact on survival.
@ast
Correlation of COX-2 and Ep-CA ...... er and its impact on survival.
@en
prefLabel
Correlation of COX-2 and Ep-CA ...... er and its impact on survival.
@ast
Correlation of COX-2 and Ep-CA ...... er and its impact on survival.
@en
P2093
P2860
P356
P1476
Correlation of COX-2 and Ep-CA ...... er and its impact on survival.
@en
P2093
A Amberger
E Gunsilius
R Margreiter
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600741
P407
P577
2003-02-01T00:00:00Z